Diloxanide furoate is primarily used as an antiparasitic agent to treat intestinal infections caused by amoebas, particularly Entamoeba histolytica. It is effective in eliminating the cyst form of the parasite, which is responsible for the spread of infection. The chemical is often prescribed in combination with other medications, such as metronidazole, to ensure comprehensive treatment of both the active and dormant stages of the infection. It is commonly administered orally and is well-tolerated, making it a reliable option for managing amoebic dysentery and asymptomatic cyst passers. Its use is crucial in preventing the transmission of amoebiasis in endemic regions.